GTCR/Surmodics: FTC Staff Raises Concerns About Deal Creating Dominant Maker of Coatings for Medical Devices

Published on Jan 28, 2025

GTCR’s attempted $627 million takeover of Surmodics (SRDX) could be in jeopardy as FTC staff raises concerns that the deal would transform the acquirer into the dominant maker of coatings for a number of medical devices, sources familiar with the matter said.

The Trade Desk: Adtech Company Reports Low Opt-Out Numbers Despite Developing Unique Identifier Tied to 245 Million Individuals

Last year only nine Californians asked The Trade Desk (TTD) to delete personal data processed by the company, despite the adtech giant developing and utilizing a persistent identifier created from...

Jul 10, 2025 Read Now >

ADNOC/Covestro: Deal Headed for In-Depth EU Subsidy Probe, Sources Say

ADNOC’s €14.7 billion planned acquisition of chemicals producer Covestro (ETR: 1CO) is likely headed for an in-depth EU foreign subsidies investigation at the end of this month because the...

Jul 07, 2025 Read Now >

T-Mobile/UScellular: Team Telecom’s Deference Gives DOJ, FCC Flexibility to Penalize Buyer If It Violates Agreement

When the interagency panel known as Team Telecom declined last month to recommend action on T-Mobile US’s (TMUS) $4.4 billion bid for United States Cellular’s (USM) wireless business, it was seen...

Jul 03, 2025 Read Now >

GTCR/Surmodics: FTC Staff Raises Concerns About Deal Creating Dominant Maker of Coatings for Medical Devices

RELATED ARTICLES | Editor’s picks

The Trade Desk: Adtech Company Reports Low Opt-Out Numbers Despite Developing Unique Identifier Tied to 245 Million Individuals

ADNOC/Covestro: Deal Headed for In-Depth EU Subsidy Probe, Sources Say

T-Mobile/UScellular: Team Telecom’s Deference Gives DOJ, FCC Flexibility to Penalize Buyer If It Violates Agreement

FILTER BY

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.